Vanderbilt Ingram Cancer Center

The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall. Read More

John F. Brock III, chairman and CEO of Coca-Cola Enterprises, his wife, Mary, and their three children have established an endowment to support an oncology fellowship at Vanderbilt-Ingram Cancer Center. The Brock Family Fellowship will provide financial assistance long into the future for young physicians, postdoctoral students and medical investigators who are furthering their training in cancer research. Read More

Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). Read More

Vanderbilt-Ingram Cancer Center leaders formally dedicated the space for the new Center for Cancer Targeted Therapies (CCTT), located in the Infusion Center on the second floor of The Vanderbilt Clinic, at a special ribbon-cutting held during last week’s fall meeting of the Cancer Center’s Board of Overseers. Read More

There are nearly 13 million cancer survivors in the United States thanks to intensive cancer research, improved treatments and cancer support programs. In celebration of cancer survivors and those patients who have passed away from the disease, Vanderbilt-Ingram Cancer Center, in partnership with Gilda’s Club Nashville, will host the 2013 Cancer Survivorship Celebration. Read More

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. Read More

Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch. Read More

Physical fatigue, anxiety and emotional distress are just some of the symptoms that caregivers may experience while undertaking the hard work of helping a friend or loved one cope with cancer. Read More

Join an upcoming live Facebook Chat in which Vanderbilt-Ingram Cancer Center experts will answer your questions about hereditary cancer risk on Sept. 24 at 6 p.m. Read More

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read More

A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies. Read More

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments. Read More

Vanderbilt will add a new race event, the 2013 Nashville Undy 5000, to the list of affiliated events for the upcoming fall season. Read More

Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding. Read More

Maury Regional Medical Center (MRMC) and Vanderbilt-Ingram Cancer Center (VICC) have joined forces to open a new radiation oncology treatment center for cancer patients in Spring Hill, Tenn. Read More

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor. Read More

On Tuesday, award-winning country music star Martina McBride and a group of her fans presented a check for $40,550 in support of cancer research at Vanderbilt-Ingram Cancer Center. Read More

The Vanderbilt Breast Center is piloting new measures to ensure continuity of care and timely insurance preauthorization as patients come off grant-sponsored clinical trial protocols and begin or resume standard care. Read More

Jordan Berlin, M.D., professor of Medicine and Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has received the Tree of Life award from Debbie’s Dream Foundation: Curing Stomach Cancer (DDF). Read More

(photo by Steve Green Steve Wolff, M.D., left, was honored at the VICC Stem Cell Transplant Survivors Reunion for his leadership in the development of the Vanderbilt Stem Cell Transplant Program in the early 1980s. John Greer, M.D., presented Wolff, a lifelong fan of the New York… Read More